» AviaraDx Confirms That Combination Of Two Molecular Biomarkers Improves Prediction Of Disease Recurrence In Early Stage Breast Cancer Patients
AviaraDx, Inc. announced the publication of an article describing the discovery, development and validation of a new molecular biomarker, Aviara MGI(SM) (Molecular Grade Index), that improves the…